Answers are grounded in this paper and cite their sources.
ObjectiveKetamine has transformed depression research by demonstrating rapid antidepressant effects through mechanisms beyond monoaminergic neurotransmission. This perspective argues that the ketamine story also provides an opportunity to re-examine broader conceptual and methodological challenges in depression research, including the definition of treatment-resistant depression, patient selection, recruitment strategies, outcome measures and the interpretation of clinical trials.ConclusionsRather than questioning whether ketamine works, this perspective asks whether depression research generates evidence that meaningfully informs clinical decisions. Differences in patient populations, recruitment strategies, expectations and outcome measures may substantially shape treatment estimates. More precise clinical characterisation and greater emphasis on patient-important outcomes may help bridge the gap between efficacy demonstrated in trials and the choice of treatment for individual patients.
No takes yet. Share an insight, caveat, or question.
Pouya Movahed (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: